A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus

PURPOSE: To compare the safety and efficacy of 0.1% riboflavin in two different solutions which is used in corneal collagen crosslinking (CXL) for the treatment of keratoconus. METHODS: This was a prospective, randomized, comparison study which included 100 eyes of 61 patients with progressive kerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Brar, Sheetal, Ganesh, Sri, Reddy, Shilpa S, BN, Nagesh, Shahanand, Dhwni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232965/
https://www.ncbi.nlm.nih.gov/pubmed/34188439
http://dx.doi.org/10.2147/OPTH.S313647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232965/
https://www.ncbi.nlm.nih.gov/pubmed/34188439
http://dx.doi.org/10.2147/OPTH.S313647

Ejemplares similares